Arguing for an Emphasis on Comparative Organelle Biology

Key Takeaways

• Organelle-level comparisons address limits of genome‑centric aging studies
• Longevity requires sustained mitochondrial and lysosomal integrity across decades
• CMLCA integrates multi‑omics across mammals to map organelle resilience
• Findings could guide gene‑therapy targets like naked‑mole‑rat cGAS
• Holistic organelle insights may accelerate human healthspan interventions

Pulse Analysis

The field of comparative gerontology has long relied on genome‑wide analyses to pinpoint the molecular hallmarks of aging. Although this strategy has uncovered key pathways, it often overlooks the structural and functional integrity of cellular organelles, which are critical for maintaining tissue health over decades. As interventions that extend lifespan in flies or mice frequently falter in human trials, scientists are recognizing that a deeper, organelle‑centric view may bridge this translational gap.

Enter the Comparative Metabolic Longevity Cell Atlas (CMLCA), a cross‑mammalian platform that standardizes cellular systems and applies organelle‑resolved proteomics, metabolomics, and lipidomics. By profiling mitochondria, lysosomes, and other organelles in species ranging from short‑lived rodents to long‑lived primates, CMLCA aims to map conserved resilience networks that support cellular function throughout an organism’s life. Early data suggest that longevity correlates with enhanced mitochondrial DNA repair capacity and robust lysosomal clearance, echoing promising results from naked‑mole‑rat cGAS experiments that improved DNA repair in mice and flies.

If successful, this organelle‑focused framework could reshape drug discovery and gene‑therapy pipelines. Researchers may target conserved organelle maintenance mechanisms rather than isolated genes, potentially yielding interventions that are effective across diverse human populations. Moreover, the atlas provides a computational resource for predicting how modifications to organelle networks influence healthspan, accelerating the move from bench to bedside. As the geroscience community embraces this holistic perspective, the prospect of translating longevity insights into real‑world therapies becomes increasingly tangible.